ITRM20080027A1 - USE OF ACICLOVIR FOR THE TREATMENT OF CONDILOMATOSIS. - Google Patents

USE OF ACICLOVIR FOR THE TREATMENT OF CONDILOMATOSIS.

Info

Publication number
ITRM20080027A1
ITRM20080027A1 IT000027A ITRM20080027A ITRM20080027A1 IT RM20080027 A1 ITRM20080027 A1 IT RM20080027A1 IT 000027 A IT000027 A IT 000027A IT RM20080027 A ITRM20080027 A IT RM20080027A IT RM20080027 A1 ITRM20080027 A1 IT RM20080027A1
Authority
IT
Italy
Prior art keywords
condilomatosis
aciclovir
treatment
Prior art date
Application number
IT000027A
Other languages
Italian (it)
Inventor
Maria Balestrieri
Original Assignee
Maria Balestrieri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Balestrieri filed Critical Maria Balestrieri
Priority to IT000027A priority Critical patent/ITRM20080027A1/en
Priority to PCT/IT2008/000116 priority patent/WO2009090679A1/en
Publication of ITRM20080027A1 publication Critical patent/ITRM20080027A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000027A 2008-01-18 2008-01-18 USE OF ACICLOVIR FOR THE TREATMENT OF CONDILOMATOSIS. ITRM20080027A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000027A ITRM20080027A1 (en) 2008-01-18 2008-01-18 USE OF ACICLOVIR FOR THE TREATMENT OF CONDILOMATOSIS.
PCT/IT2008/000116 WO2009090679A1 (en) 2008-01-18 2008-02-21 Use of acyclovir for the treatment of condylomatosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000027A ITRM20080027A1 (en) 2008-01-18 2008-01-18 USE OF ACICLOVIR FOR THE TREATMENT OF CONDILOMATOSIS.

Publications (1)

Publication Number Publication Date
ITRM20080027A1 true ITRM20080027A1 (en) 2009-07-19

Family

ID=39361419

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000027A ITRM20080027A1 (en) 2008-01-18 2008-01-18 USE OF ACICLOVIR FOR THE TREATMENT OF CONDILOMATOSIS.

Country Status (2)

Country Link
IT (1) ITRM20080027A1 (en)
WO (1) WO2009090679A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
EP1463500A1 (en) * 2002-01-10 2004-10-06 PHARMACIA & UPJOHN COMPANY Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
AU2003240213A1 (en) * 2002-06-24 2004-01-06 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050272700A1 (en) * 2004-05-10 2005-12-08 Servet Buyuktimkin Topical treatment and prevention of human papilloma virus (HPV) infection

Also Published As

Publication number Publication date
WO2009090679A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
LTPA2020006I1 (en) GDF traps for use in the treatment of anemia
SMP200900085B (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative.
SMT201400008B (en) Use of bethanecol for the treatment of xerostomia
DK2504005T3 (en) USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES
BRPI0823082A2 (en) Use sesquiterpene derivatives
BRPI0911577A2 (en) spiroindole derivatives for the treatment of parasitic diseases.
IT1396935B1 (en) USE OF A COMBINATION FOR THE TREATMENT OF MUCOSITES INDUCED BY RADIATION OR CHEMOTHERAPY
BRPI0922233A2 (en) compounds, pharmaceutical compositions and methods for use in the treatment of metabolic syndromes.
ITMI20052204A1 (en) USE OF COLOSTRO FOR THE PROPHYLAXIS OF INFLUENCIAL SYNDRONS
ITMI20080003A1 (en) COMPOSITIONS FOR OPHTHALMIC USE
IT1391866B1 (en) INJECTIONABLE COMPOSITION OF POLYNUCLEOTIDS FOR THE TREATMENT OF OSTEOARTICULAR DISEASES.
BRPI0820440A2 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders.
SMT201500086B (en) Use of nifuratel for the treatment of infections caused by the atopobium species
ITRM20050179A1 (en) APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
BRPI0915905A2 (en) use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
NO20082126L (en) Adjustment device for the chair arms
FR2930124B1 (en) DISABLED FURNITURE
SMT201400087B (en) Use of histone-deacetylase inhibitors for the treatment of philadelphia-negative myeloproliferative syndromes
BRPI0907956A2 (en) Use of ranolazine for the treatment of cardiovascular disease
ITMI20080195A1 (en) PROCEDURE FOR THE PREPARATION OF SOLIFENACIN
BRPI0822637A2 (en) Use of lanosta-8,24-dien-3-ol
ITRM20080037A1 (en) PROCEDURE FOR THE ULTRAPURIFICATION OF ALGINATI.
BRPI0919816A2 (en) use benzoxazole compounds in the treatment of malaria
IT1397000B1 (en) USE OF A PREPARATION BASED ON NIFEDIPINE FOR THE TREATMENT OF VAGINISM
DK2121682T3 (en) 4- (pyrrolopyridyl) pyrimidin-2-ylamine DERIVATIVES